查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1808846

分子製药市场，按产品类型、按植物类型、按应用、按最终用户、按国家和地区 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

Molecular Pharming Market, By Product Type, By Plant Type, By Application, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 389 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年分子製药市场规模价值 17.8724 亿美元，2025 年至 2032 年的复合年增长率为 8.5%。

分子製药市场涉及利用基因改造植物生产疫苗、抗体、酵素和治疗性蛋白质等药物。这种创新的生物终端使用者製程透过插入编码所需治疗性蛋白质的特定基因，将植物转化为生物工厂。分子製药提供了一种经济高效、可扩展且更安全的替代传统细胞或微生物发酵方法的方法。它消除了人类病原体污染的风险，并可在健康危机期间快速部署。

烟草、玉米和水稻等作物因其生长迅速且易于基因操作而被广泛使用。最终用户因其可能彻底改变疫苗生产（尤其是在资源匮乏的地区）而备受关注。监管框架正在不断发展，以解决安全性和有效性问题，有助于加速市场采用。随着生技研发投资的增加，尤其是在传染病、癌症和罕见疾病领域，对疫苗的需求也不断增加。

分子药市场-市场动态

在资源匮乏和流行病流行的情况下，对植物疫苗的需求不断增加。

分子製药市场的一个关键利基驱动因素是植物疫苗需求的不断增长，尤其是在资源匮乏的地区和疫情期间。传统的疫苗生产方法通常依赖昂贵的基础设施、冷链和漫长的生产週期，这使得它们在发展中地区难以获得。分子製药提供了一种解决方案，它能够利用可在当地种植、资源极少的植物，实现快速、可扩展且经济高效的生产。

在全球卫生紧急情况下，速度和可扩展性至关重要，这种方法尤其重要。植物基系统还能降低被动物或人类病原体污染的风险。此外，基因工程的进步提高了植物性疫苗研发的精准度和效率。生产口服或食用疫苗的能力也开启了更容易分发的新型给药方式。这种日益增长的兴趣支持分子製药成为实现全球公平医疗保健的策略工具。

分子製药市场—关键见解

根据我们的研究分析师的分析，预测期内（2025-2032 年）全球市场预计年复合成长率约为 8.5%

根据产品类型细分，预计疫苗将在 2024 年占据最大市场份额

根据植物类型细分，烟草是 2024 年的主要植物类型

根据应用细分，传染病是 2024 年的主要应用

根据最终用户细分，製药公司是 2024 年的主要应用

从地区来看，北美是 2024 年最大的收入来源

分子药物市场-細項分析：

全球分子药物市场根据产品类型、植物类型、应用、最终用户和地区进行细分。

根据产品类型，市场分为三类：疫苗、单株抗体、治疗性蛋白、酵素和诊断性蛋白。依产品类型划分，分子製药市场中最主要的市场区隔是疫苗。与传统方法相比，透过分子製药生产的疫苗因其快速、大规模且经济高效的生产潜力而获得了显着的吸引力。植物性疫苗的研发速度更快，这在时间紧迫的疫情爆发和疫情期间至关重要。此外，由于植物不携带人类病原体，分子製药可以生产更安全的疫苗，从而降低污染风险。

这个细分市场受惠于全球对平价疫苗日益增长的需求，尤其是在传统疫苗生产基础设施有限的发展中国家。基因工程的进步提高了疫苗在植物系统中的效力和稳定性。人们对流感、新冠肺炎和其他病毒感染等传染病的日益关注，进一步推动了这个细分市场的成长。此外，监管机构正在逐步製定更清晰的植物源疫苗框架，以支持市场扩张。总体而言，疫苗仍然是领先的产品类型，推动了分子製药市场的成长和创新。

根据植物类型，市场分为四类：烟草、玉米、水稻、马铃薯、藻类和其他。按植物类型划分，烟草在分子製药市场中占据主导地位。烟草植物因其生长速​​度快、生物量高且基因改造技术成熟而备受青睐。与粮食作物不同，烟草不供人类食用，这最大限度地减少了食品供应链中交叉污染的担忧。烟草叶片为生产大量药用蛋白（包括疫苗和单株抗体）提供了理想的平台。

此外，烟草能够在温室等受控环境中生长，从而实现持续且可扩展的生产。许多领先的生物技术公司利用烟草植物在卫生紧急情况下快速反应，包括生产传染病抗体。围绕烟草作为宿主植物的广泛研究和基础设施建设使其比其他植物类型更具竞争优势。因此，烟草仍然是分子製药植物类型的首选，推动了市场的显着成长。

分子製药市场—地理洞察

北美引领全球分子製药市场，这得益于其先进的基础设施、大量的研发投入以及有利的监管环境。尤其是美国，拥有众多生技公司和研究机构，它们正在开拓植物性药物的生产。该地区受益于强大的医疗保健体系、高昂的医疗支出以及优惠的报销政策，从而促进了创新疗法的推广。产业领袖、学术机构和政府机构之间的合作加速了分子製药技术的发展。

美国在分子製药市场中处于领先地位，这得益于其强大的基础设施、大量的研发投入以及良好的监管环境。美国先进的生物终端用户领域拥有尖端的研究机构、完善的实验室和完善的供应链网络，从而促进了分子製药产品的高效开发和应用。政府措施发挥关键作用，提供财政激励措施并促进产学合作，加速创新和商业化进程。

分子製药市场-竞争格局：

分子製药市场竞争激烈，主要由肯塔基生物处理公司 (Kentucky Bioprocessing)、Medicago、iBio、Ventria Bioscience 和 Protalix BioTherapeutics 等主要参与者主导。这些公司高度重视创新，以提高植物的蛋白质表现和生产效率。他们与学术机构和政府机构的策略伙伴关係十分常见，这有助于加速研发和监管批准。智慧财产权保护至关重要，许多参与者透过申请专利来保持竞争优势。

为了确保一致的品质和可扩展性，对先进培养技术（包括受控环境农业和生物反应器）的投资正在增加。此外，企业透过瞄准疫苗和单株抗体等特定治疗领域来脱颖而出。应对复杂的监管框架仍然是一项挑战，同时也是进入市场的壁垒，这使得老牌企业得以巩固其地位。总体而言，竞争推动了技术进步和分子製药解决方案的更广泛应用。

最新动态：

2024 年 10 月，Moolec Science 获得美国监管部门批准，可生产富含铁的牛肌红蛋白的基因改造豌豆 (PEEA1)，为消费者提供植物性铁来源。

2024 年 2 月，纽西兰食品科技新创公司 Miruku 在 A 轮融资前筹集了 500 万美元，用于扩大其旨在生产乳製品蛋白质和脂肪的分子农业平台。

目录

第一章：分子製药市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 分子製药市场依产品类型划分
    • 分子製药市场（按植物类型）摘要
    • 分子製药市场片段（按应用）
    • 分子製药市场片段（按最终用户）
    • 分子製药市场（按国家）摘要
    • 分子製药市场（按地区）
  • 竞争洞察

第三章：分子製药关键市场趋势

  • 分子药物市场驱动因素
    • 市场驱动因素的影响分析
  • 分子药物市场限制
    • 市场限制的影响分析
  • 分子製药市场机会
  • 分子製药市场未来趋势

第四章：分子製药业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：分子製药市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：分子製药市场格局

  • 2024年分子製药市占率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：分子药市场－依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 疫苗
    • 单株抗体
    • 治疗性蛋白质
    • 酵素
    • 诊断蛋白

第八章：分子製药市场－依植物类型

  • 概述
    • 按工厂类型分類的细分市场份额分析
    • 烟草
    • 玉米
    • 米
    • 马铃薯
    • 藻类
    • 其他的

第九章：分子製药市场－依应用

  • 概述
    • 按应用细分市场占有率分析
    • 传染病
    • 癌症
    • 罕见疾病
    • 自体免疫疾病
    • 其他的

第 10 章：分子製药市场 - 按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 製药公司
    • 生技公司
    • 研究机构
    • 合约研究组织（CRO）

第 11 章：分子药物市场 - 按地理划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美分子製药主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模及预测（按工厂类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模及预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲分子製药主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模及预测（按工厂类型）
    • 欧洲市场规模和预测，按应用
    • 欧洲市场规模及预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区分子製药主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（依产品类型）
    • 亚太地区市场规模及预测（依工厂类型）
    • 亚太地区市场规模及预测（按应用）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲分子製药主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（依产品类型）
    • 拉丁美洲市场规模及预测（依工厂类型）
    • 拉丁美洲市场规模及预测（按应用）
    • 拉丁美洲市场规模及预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲的分子製药主要製造商
    • MEA 市场规模及预测（依国家/地区）
    • MEA 市场规模及预测（依产品类型）
    • MEA 市场规模及预测（依工厂类型）
    • MEA 市场规模及预测（按应用）
    • MEA 市场规模及预测（依最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 12 章：分子製药产业主要供应商分析

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Kentucky Bioprocessing
    • Medicago
    • iBio
    • Ventria Bioscience
    • Protalix BioTherapeutics
    • PlantForm Corporation
    • Caliber Biotherapeutics
    • Fraunhofer USA
    • Icon Genetics
    • Greenovation Biotech
    • Dow AgroSciences
    • Zymeworks
    • Bayer CropScience
    • Cibus
    • PlantVax Inc.
    • AquaBounty Technologies
    • Phyton Biotech
    • Vaxess Technologies
    • Medicago Inc.
    • PlantForm Corp

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5495

Molecular Pharming Market size was valued at US$ 1,787.24 Million in 2024, expanding at a CAGR of 8.5% from 2025 to 2032.

The Molecular Pharming Market involves the use of genetically modified plants to produce pharmaceutical substances such as vaccines, antibodies, enzymes, and therapeutic proteins. This innovative bioEnd-user process transforms plants into biofactories by inserting specific genes that encode the desired therapeutic proteins. Molecular pharming offers a cost-effective, scalable, and safer alternative to traditional cell-based or microbial fermentation methods. It eliminates the risk of contamination from human pathogens and can be rapidly deployed during health crises.

Crops like tobacco, maize, and rice are commonly used due to their fast growth and ease of genetic manipulation. The End-user has gained attention for its potential to revolutionize vaccine production, especially in low-resource settings. Regulatory frameworks are evolving to address safety and efficacy concerns, helping accelerate market adoption. Demand is rising with increased investment in biotech R&D, especially for infectious diseases, cancer, and rare disorders.

Molecular Pharming Market- Market Dynamics

Rising demand for plant-based vaccines in low-resource and pandemic scenarios.

A key niche driver for the molecular pharming market is the rising demand for plant-based vaccines, especially in low-resource settings and during pandemic scenarios. Traditional vaccine production methods often rely on expensive infrastructure, cold chains, and long manufacturing timelines, making them less accessible in developing regions. Molecular pharming offers a solution by enabling rapid, scalable, and cost-effective production using plants, which can be grown locally with minimal resources.

This approach is particularly valuable during global health emergencies when speed and scalability are critical. Plant-based systems also reduce the risk of contamination with animal or human pathogens. Furthermore, advances in genetic engineering have enhanced the precision and efficiency of plant-based vaccine development. The ability to produce oral or edible vaccines also opens up new delivery methods that are easier to distribute. This growing interest supports molecular pharming as a strategic tool for equitable global healthcare.

Molecular Pharming Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2025-2032)

Based on product type segmentation, vaccines were predicted to show maximum market share in the year 2024

Based on Plant Type segmentation, tobacco was the leading Plant Type in 2024

Based on Application segmentation, Infectious Diseases were the leading Application in 2024

Based on End-User segmentation, Pharmaceutical Companies were the leading Application in 2024

Based on region, North America was the leading revenue generator in 2024

Molecular Pharming Market- Segmentation Analysis:

The Global Molecular Pharming Market is segmented on the basis of Product Type, Plant Type, Application, End-user, and Region.

The market is divided into three categories based on product type: Vaccines, Monoclonal Antibodies, Therapeutic Proteins, Enzymes, and Diagnostic Proteins. The most dominant segment in the molecular pharming market by product type is vaccines. Vaccines produced through molecular pharming have gained significant traction due to their potential for rapid, large-scale, and cost-effective production compared to traditional methods. Plant-based vaccines can be developed faster, which is crucial during outbreaks and pandemics where time is critical. Additionally, molecular pharming allows for the production of safer vaccines, as plants do not carry human pathogens, reducing contamination risks.

This segment benefits from growing global demand for affordable vaccines, especially in developing countries where traditional vaccine manufacturing infrastructure is limited. Advances in genetic engineering have improved vaccine efficacy and stability in plant systems. The increasing focus on infectious diseases, such as influenza, COVID-19, and other viral infections, further drives growth in this segment. Furthermore, regulatory agencies are gradually developing clearer frameworks for plant-derived vaccines, supporting market expansion. Overall, vaccines remain the leading product type, fueling the growth and innovation within the molecular pharming market.

The market is divided into four categories based on Plant Type: Tobacco, Maize (Corn), Rice, Potato, Algae, and Others. The tobacco segment is the most dominant in the molecular pharming market by plant type. Tobacco plants are preferred due to their fast growth rate, high biomass yield, and well-established genetic modification techniques. Unlike food crops, tobacco is not used for human consumption, which minimizes concerns about cross-contamination in the food supply chain. Its leaves provide an ideal platform for producing large quantities of pharmaceutical proteins, including vaccines and monoclonal antibodies.

Additionally, tobacco's ability to be grown in controlled environments such as greenhouses allows for consistent and scalable production. Many leading biotech companies have leveraged tobacco plants for rapid response during health emergencies, including producing antibodies for infectious diseases. The extensive research and infrastructure around tobacco as a host plant give it a competitive advantage over other plant types. As a result, tobacco continues to be the preferred choice for molecular pharming Plant Types, driving significant market growth.

Molecular Pharming Market- Geographical Insights

North America leads the global molecular pharming market, driven by its advanced infrastructure, substantial R&D investments, and a supportive regulatory environment. The United States, in particular, hosts numerous biotech firms and research institutions that are pioneering plant-based pharmaceutical production. This region benefits from a robust healthcare system, high healthcare expenditures, and favorable reimbursement policies, facilitating the adoption of innovative therapies. Collaborations between industry leaders, academic institutions, and government agencies have accelerated the development of molecular pharming technologies.

The United States stands at the forefront of the molecular pharming market, driven by a confluence of robust infrastructure, substantial R&D investments, and a supportive regulatory environment. The nation's advanced bioEnd-user sector is characterized by cutting-edge research institutions, well-established laboratories, and a comprehensive supply chain network, facilitating the efficient development and Application of molecular pharming products. Government initiatives play a pivotal role, offering financial incentives and fostering collaborations between industry, academia, and research institutions, thereby accelerating innovation and commercialization.

Molecular Pharming Market- Competitive Landscape:

The molecular pharming market features a competitive landscape dominated by key players such as Kentucky Bioprocessing, Medicago, iBio, Ventria Bioscience, and Protalix BioTherapeutics. These companies focus heavily on innovation to improve protein expression and production efficiency in plants. Strategic partnerships with academic institutions and government bodies are common, helping to accelerate R&D and regulatory approvals. Intellectual property protection is a critical factor, with many players securing patents to maintain their competitive edge.

Investments in advanced cultivation technologies, including controlled environment agriculture and bioreactors, are increasing to ensure consistent quality and scalability. Additionally, companies differentiate themselves by targeting specific therapeutic areas like vaccines and monoclonal antibodies. Navigating complex regulatory frameworks remains a challenge but also a barrier to entry, allowing established players to strengthen their positions. Overall, the competition drives technological progress and wider adoption of molecular pharming solutions.

Recent Developments:

In October 2024, Moolec Science obtained U.S. regulatory approval for genetically engineered peas (PEEA1) that produce iron-rich bovine myoglobin, offering a plant-based source of iron for consumers.

In February 2024, New Zealand-based food tech startup Miruku raised $5 million in a pre-Series A financing round to expand its molecular farming platform aimed at producing dairy proteins and fats.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MOLECULAR PHARMING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Kentucky Bioprocessing
  • Medicago
  • iBio
  • Ventria Bioscience
  • Protalix BioTherapeutics
  • PlantForm Corporation
  • Caliber Biotherapeutics
  • Fraunhofer USA
  • Icon Genetics
  • Greenovation Biotech
  • Dow AgroSciences
  • Zymeworks
  • Bayer CropScience
  • Cibus
  • PlantVax Inc.
  • AquaBounty Technologies
  • Phyton Biotech
  • Vaxess Technologies
  • Medicago Inc.
  • PlantForm Corp.

GLOBAL MOLECULAR PHARMING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Vaccines
  • Monoclonal Antibodies
  • Therapeutic Proteins
  • Enzymes
  • Diagnostic Proteins

GLOBAL MOLECULAR PHARMING MARKET, BY PLANT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Tobacco
  • Maize (Corn)
  • Rice
  • Potato
  • Algae
  • Others

GLOBAL MOLECULAR PHARMING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Infectious Diseases
  • Cancer
  • Rare Diseases
  • Autoimmune Disorders
  • Others

GLOBAL MOLECULAR PHARMING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Research Institutes
  • Contract Research Organizations (CROs)

GLOBAL MOLECULAR PHARMING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Molecular Pharming Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Molecular Pharming Market Snippet by Product Type
    • 2.1.2. Molecular Pharming Market Snippet by Plant Type
    • 2.1.3. Molecular Pharming Market Snippet by Application
    • 2.1.4. Molecular Pharming Market Snippet by End-user
    • 2.1.5. Molecular Pharming Market Snippet by Country
    • 2.1.6. Molecular Pharming Market Snippet by Region
  • 2.2. Competitive Insights

3. Molecular Pharming Key Market Trends

  • 3.1. Molecular Pharming Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Molecular Pharming Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Molecular Pharming Market Opportunities
  • 3.4. Molecular Pharming Market Future Trends

4. Molecular Pharming Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Molecular Pharming Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Molecular Pharming Market Landscape

  • 6.1. Molecular Pharming Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Molecular Pharming Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Vaccines
    • 7.1.3. Monoclonal Antibodies
    • 7.1.4. Therapeutic Proteins
    • 7.1.5. Enzymes
    • 7.1.6. Diagnostic Proteins

8. Molecular Pharming Market - By Plant Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Plant Type, 2024 & 2032 (%)
    • 8.1.2. Tobacco
    • 8.1.3. Maize (Corn)
    • 8.1.4. Rice
    • 8.1.5. Potato
    • 8.1.6. Algae
    • 8.1.7. Others

9. Molecular Pharming Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Infectious Diseases
    • 9.1.3. Cancer
    • 9.1.4. Rare Diseases
    • 9.1.5. Autoimmune Disorders
    • 9.1.6. Others

10. Molecular Pharming Market - By End-user

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 10.1.2. Pharmaceutical Companies
    • 10.1.3. Biotechnology Companies
    • 10.1.4. Research Institutes
    • 10.1.5. Contract Research Organizations (CROs)

11. Molecular Pharming Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Molecular Pharming Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Molecular Pharming Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Molecular Pharming Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Molecular Pharming Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Molecular Pharming Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Molecular Pharming Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Kentucky Bioprocessing
    • 12.2.2. Medicago
    • 12.2.3. iBio
    • 12.2.4. Ventria Bioscience
    • 12.2.5. Protalix BioTherapeutics
    • 12.2.6. PlantForm Corporation
    • 12.2.7. Caliber Biotherapeutics
    • 12.2.8. Fraunhofer USA
    • 12.2.9. Icon Genetics
    • 12.2.10. Greenovation Biotech
    • 12.2.11. Dow AgroSciences
    • 12.2.12. Zymeworks
    • 12.2.13. Bayer CropScience
    • 12.2.14. Cibus
    • 12.2.15. PlantVax Inc.
    • 12.2.16. AquaBounty Technologies
    • 12.2.17. Phyton Biotech
    • 12.2.18. Vaxess Technologies
    • 12.2.19. Medicago Inc.
    • 12.2.20. PlantForm Corp

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us